Column Group LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Column Group LLC reported 6 stock positions worth $69.6 million. Its top holding was Oric Pharmaceuticals (ORIC) at 52.2% of the portfolio, followed by Tenaya Therapeutics (TNYA, 26.1%) and Surrozen (SRZN, 13.9%). Its holdings were unchanged from Q2 2024.
- Most Recent 13F
- Q2 2026
- Location
- San Francisco, CA
- CIK
- 0001833486
- Portfolio Value
- $69.6M (Q3 2024)
- SEC Filing
- 0000950123-24-011839 ↗ filed Nov 14, 2024
Holdings Value
Holdings 6 stocks · $69.6M
| ORIC Oric Pharmaceuticals Inc. | 52.16% | 3,540,777 | $36.3M | No change |
| TNYA Tenaya Therapeutics Inc. | 26.08% | 9,400,290 | $18.1M | No change |
| SRZN Surrozen Inc. | 13.95% | 810,088 | $9.7M | No change |
| RAPT THERAPEUTICS INC | 7.74% | 2,680,621 | $5.4M | No change |
| SGMT Sagimet Biosciences Inc. Class A | 0.07% | 17,169 | $48K | No change |
| RVMD Revolution Medicines Inc. | 0.00% | 46 | $2K | No change |
Portfolio Sells Q2 2024 → Q3 2024
| None this quarter. | |||
Portfolio Buys Q2 2024 → Q3 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 3 | $88.1M | SRZN, ORIC, RVMD |
| Q1 2026 | 3 | $100.7M | SRZN, ORIC, RVMD |
| Q4 2025 | 5 | $82.8M | SRZN, ORIC, TNYA, RAPT THERAPEUTICS INC, RVMD |
| Q3 2025 | 5 | $81.0M | ORIC, SRZN, TNYA, RAPT THERAPEUTICS INC, RVMD |
| Q2 2025 | 5 | $65.7M | ORIC, SRZN, RAPT THERAPEUTICS INC, TNYA, RVMD |
| Q1 2025 | 5 | $44.2M | ORIC, SRZN, TNYA, RAPT THERAPEUTICS INC, RVMD |
| Q4 2024 | 5 | $55.7M | ORIC, TNYA, SRZN, RAPT THERAPEUTICS INC, RVMD |
| Q3 2024 | 6 | $69.6M | ORIC, TNYA, SRZN, RAPT THERAPEUTICS INC, SGMT |
| Q2 2024 | 6 | $71.3M | TNYA, ORIC, SRZN, RAPT THERAPEUTICS INC, SGMT |
| Q1 2024 | 7 | $160.5M | TNYA, ORIC, NGM, RAPT THERAPEUTICS INC, SRZN |